you are here:

Lyka Labs Ltd.

BSE: 500259 | NSE: LYKALABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE933A01014 | SECTOR: Pharmaceuticals

BSE Live

Dec 03, 16:00
190.55 9.05 (4.99%)
Volume
AVERAGE VOLUME
5-Day
469,501
10-Day
1,051,199
30-Day
407,024
347,565
  • Prev. Close

    181.50

  • Open Price

    190.55

  • Bid Price (Qty.)

    190.55 (46479)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 03, 15:59
189.80 9.00 (4.98%)
Volume
AVERAGE VOLUME
5-Day
947,993
10-Day
545,394
30-Day
584,150
1,073,097
  • Prev. Close

    180.80

  • Open Price

    188.50

  • Bid Price (Qty.)

    189.80 (104018)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Lyka Labs

  • Nov 24, 2021 19:13 Source: BSE

    Lyka Labs - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ipca Laboratories Ltd

  • Nov 24, 2021 9:40 Source: BSE

    Lyka Labs - Public Announcement To Equity Shareholders Of Lyka Labs Limited

    Please find enclosed herewith the Public announcement to equity shareholders of Lyka Labs Limited

  • Nov 24, 2021 9:32 Source: NSE

    Lyka Labs Limited

    Arihant Capital Markets Ltd ("Managers to the Offer") has submitted to the Exchange a copy of Public Announcement for Open offer of Lyka Labs Limited ("Target Company")

  • Nov 24, 2021 8:50 Source: BSE

    Lyka Labs - Open Offer

    Arihant Capital Markets Ltd ("Managers to the Offer") has submitted to BSE a copy of Public Announcement to Equity Shareholders of Lyka Labs Ltd ("Target Company").

  • Nov 24, 2021 8:50 Source: BSE

    Lyka Labs - Public Announcement

    Arihant Capital Markets Ltd ("Managers to the Offer") has submitted to BSE a copy of Public Announcement to Equity Shareholders of Lyka Labs Ltd ("Target Company").

  • Oct 29, 2021 18:44 Source: BSE

    Lyka Labs - Merger Of Lyka Exports Limited With Lyka Labs Limited

    In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered Merger of Lyka Exports Limited, a subsidiary Company with Lyka Labs Limited, Holding Company w.e.f 01 April, 2022 subject to requisite approval of Securities and Exchange Board of India (SEBI),and other applicable requisite authorities

  • Oct 29, 2021 18:14 Source: BSE

    Lyka Labs - Un-Audited Financial Results For The Quarter And Six Months Ended 30 Th September, 2021

    Un-audited Standalone and Consolidated Financial Results for the quarter and six months ended 30th September, 2021.

  • Oct 29, 2021 18:08 Source: BSE

    Lyka Labs - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th October, 2021

    In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved; 1. Un-audited Standalone and Consolidated Financial Results for the quarter and six months ended 30th September, 2021 (Enclosed). 2. Merger of Lyka Exports Limited, a subsidiary Company with Lyka Labs Limited, Holding Company w.e.f 1st April, 2022 subject to requisite approval of Securities and Exchange Board of India (SEBI), and other applicable requisite authorities. Meeting was commenced at 3.00 P.M Meeting was concluded at 5.45 P.M. This is for your information and records.

  • Oct 27, 2021 19:28 Source: BSE

    Lyka Labs - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Company received intimation from M/s Link Intime India Private Limited (Registrar and Share Transfer Agent) today regarding Issuance of duplicate share certificate. Kindly take the same on your record.

  • Oct 22, 2021 17:08 Source: BSE

    Lyka Labs - Board Meeting Intimation for Consideration Of Financial Results For The Quarter Ended 30 September, 2021

    LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2021 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors of Lyka Labs Limited is scheduled to be held on Friday, 29 October, 2021 at Corporate Office to consider and adopt Standalone and Consolidated Un-Audited Financial Results for the Second Quarter and Six Months ended on September, 30,2021. As informed earlier, the trading window is closed from October 01,2021 till48 hours after declaration of Un-Audited Financial Results. Kindly take the same on your record

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Oct 29, 2021
Remark : Quarterly Results